Human Cyclin-dependent kinase 4 inhibitor B (CDKN2B) ELISA kit

Product information

Size

96 Tests

Catalog number

EKC33342

Price

859 EUR

More information

Estimated Turnaround Time

6-11 business days

Target Name

cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)

Target's alterntive name

CDK4I, INK4B, MTS2, P15, TP15, p15INK4b, CDK inhibitory protein|CDK4B inhibitor|cyclin-dependent kinase 4 inhibitor B|cyclin-dependent kinase inhibitor 2B|cyclin-dependent kinases 4 and 6 binding pr

Species Reactivity

Human

Sample Type

serum, plasma, tissue homogenates, cell lysates

Detection Range

31.25 pg/mL-2000 pg/mL

Sensitivity

7.81 pg/mL

Precision

NA

Detection Method

Colorimetric

Assay Time

1-5 hours

Application

For research use only. Not for diagnostic procedures.

Assay Type

NA

Shipping Conditions

Ice packs

Storage Temperature

Short term: 4°C; Long term: see manual.

Precaution of Use

The Stop Solution is acidic. Do not allow to contact skin or eyes.

Shelf life

Use Human Cyclin-dependent kinase 4 inhibitor B (CDKN2B) ELISA kit before 6 months

Specificity

NA

Cross Activity

NA

Test Principle

NA

Stability

NA

Quality Systems

The kit is manufactured at ISO 9001 certified facilities.

Research Area

Cell Biology

Properties

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Test

ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

Description

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.